Patients with mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL) have high hospital costs associated with disease relapse, especially among minority populations, according to a study conducted by Asher Chanan-Khan, MBBS, MD, and colleagues. The findings were presented at the 2021 American Society of Hematology Annual Meeting. In … Continue reading Assessing Costs and Resource Utilization of Hospital-Based Care Among Patients with B-Cell Malignancies